Evolent Health, Inc. planned insider sales
In the last twelve months insiders at Evolent Health, Inc. filed 1 Form 144 notice of planned sales, 65,892 shares worth $327,476 at the time of filing, from 1 seller. The latest, filed 26 August 2026: Daniel McCarthy (officer), 65,892 shares worth $327,476, planned for around 26 August 2026 through Merrill Lynch.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 26 August 2026 | Daniel McCarthy | Officer | 65,892 | $327,476 | 26 August 2026 | 65,892 shares from 26 August 2026 | Merrill Lynch | Stock plan activity | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.